Qiagen NV, a European molecular diagnostics company, is drawing early takeover interest from private equity firms, according to people familiar with the matter cited by Bloomberg. The potential interest includes firms such as EQT AB and Advent. Investing.com also reports that early takeover discussions involve other well-known investment firms, naming KKR as among those showing interest, alongside EQT and Advent. The reports characterize the activity as preliminary, suggesting that discussions are at an early stage rather than indicating any confirmed bid, offer terms, or transaction timeline. Details on whether Qiagen is actively seeking a buyer, the size of any potential bids, or how far talks have progressed are not provided in the excerpts. No immediate comment from Qiagen is included in the provided text. The reporting therefore focuses on the existence of early interest from multiple investors rather than on the outcome of any formal process.
Qiagen draws early takeover interest from EQT and Advent, reports say
Qiagen NV, a European molecular diagnostics company, is drawing early takeover interest from private equity firms, according to people familiar with the matter cited by Bloomberg. The potential intere...
- Qiagen NV is attracting early takeover interest, according to people familiar with the matter.
- EQT AB is named as one of the firms showing interest.
- Advent is also reported to be among the potential interested parties.
- KKR is cited in one report as an additional firm showing interest.
- Reports describe the interest as preliminary, without confirming any bid or transaction terms.
Qiagen NV, the European molecular testing company, is drawing early takeover interest from firms including EQT AB and Advent, people familiar with the matter said.
1 month ago
Céline Dion returns to Paris for first concerts since Stiff Person Syndrome diagnosis
Canadian singer Céline Dion makes a rare public appearance in Paris ahead of her stage return, arriving at Hotel Le Roya...
SEBI clears Jio Platforms’ planned ₹37,700 crore IPO for listing
Jio Platforms receives approval from India’s markets regulator SEBI to proceed with its initial public offering (IPO), a...
War with the United States and tighter sanctions strain Iran’s economy
Iranian leaders acknowledge that the country’s war-related pressures and increased U.S. sanctions are taking a heavy eco...